Oncological risks associated with the planned watch-and-wait strategy using total neoadjuvant treatment for rectal cancer: A narrative review
J Socha, R Glynne-Jones, K Bujko - Cancer Treatment Reviews, 2024 - Elsevier
Overall survival benefit of total neoadjuvant treatment (TNT) remains unconfirmed. Thus, in
our opinion, the main rationale for using TNT is a planned watch-and-wait (w&w) strategy to …
our opinion, the main rationale for using TNT is a planned watch-and-wait (w&w) strategy to …
[HTML][HTML] Beyond survival: a comprehensive review of quality of life in rectal cancer patients
WB Jung - Annals of Coloproctology, 2024 - pmc.ncbi.nlm.nih.gov
Rectal cancer is one of the most common carcinomas and a leading cause of cancer-related
mortality. Although significant advancements have been made in the treatment of rectal …
mortality. Although significant advancements have been made in the treatment of rectal …
Risk factors of the low anterior resection syndrome (LARS) after ileostomy reversal in rectal cancer patient
X Zhang, Q Meng, J Du, Z Tian, Y Li, B Yu, W Niu - Scientific Reports, 2024 - nature.com
This study is aimed at identifying risk factors of Low Anterior Resection Syndrome following
ileostomy reversal in rectal cancer patients who had undergone preventive ileostomy. This …
ileostomy reversal in rectal cancer patients who had undergone preventive ileostomy. This …
Omission of Chemoradiation in Locally Advanced Rectal Adenocarcinoma: Evaluation of PROSPECT in a National Database
JT Buchheit, LM Janczewski, A Wells… - Journal of surgical …, 2024 - Wiley Online Library
ABSTRACT Background and Objectives The PROSPECT trial showed noninferiority of
neoadjuvant chemotherapy (NAC) with selective chemoradiation (CRT) versus CRT alone …
neoadjuvant chemotherapy (NAC) with selective chemoradiation (CRT) versus CRT alone …
Liver Transplantation for Cholangiocarcinoma
N Soliman, AA Connor, S Kodali… - Digestive Disease …, 2024 - thieme-connect.com
Cholangiocarcinomas (CCAs) are highly aggressive, primary liver cancers with rising
incidence and mortality rates. The current 5-year overall survival is less than 20%. There are …
incidence and mortality rates. The current 5-year overall survival is less than 20%. There are …
Изменения в клинических рекомендациях по лечению колоректального рака в 2024 году
СС Гордеев, МЮ Федянин, МВ Черных… - Хирургия и …, 2024 - onco-surgery.info
Изменения в клинических рекомендациях по лечению колоректального ра Page 1 21
ТОМ 14 / VOL. 14 1’ 2024 хирургия и онкология Surgery and oncology Обзор литературы …
ТОМ 14 / VOL. 14 1’ 2024 хирургия и онкология Surgery and oncology Обзор литературы …